ArticleOphthalmology science
Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06071546 (Pre-market Monocentric Cross-sectional Clinical Investigation of MAIA on Healthy Subjects and Patients With Retinal Pathology), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pre-market Monocentric Cross-sectional Clinical Investigation of MAIA on Healthy Subjects and Patients With Retinal Pathology: Agreement With MAIA 2013 EDITION Microperimeter and Repeatability Evaluation
Who cites it
1 citing paper in PubMed.
- How "Micro" Is Microperimetry? Characterizing the Effect of Fundus Tracking on the Psychometric Function.Investigative ophthalmology & visual science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Microperimetry is critical for the evaluation of macular light sensitivity, enabling disease monitoring in patients with either center-involving scotoma or initial sparing of the center. The purpose of this study was to investigate the validity and repeatability of light sensitivity measurements with the novel Macular Integrity Assessment (MAIA3) microperimeter compared with the established gold standard MAIA 2013 edition device (MAIA2). Design: A prospective, cross-sectional, premarket clinical investigation on a medical device in a tertiary referral center (ClinicalTrials.gov ID: NCT06071546). Participants: Thirty-four healthy volunteers (median age: 28 years, interquartile range [IQR]: [26-32] years) and 34 patients with retinal pathologies (66 years, IQR: [50.5-74.5] years) were enrolled. All participants underwent comprehensive ophthalmic evaluation, including best-corrected visual acuity testing and OCT imaging. The diagnosis of retinal disease in patients was confirmed through fundoscopy and imaging. Main Outcome Measures: Agreement between MAIA3 and MAIA2 measurements with mean sensitivity (MS) and at the pointwise sensitivity (PWS) level and test-retest (TRT) repeatability of MAIA3 and MAIA2 devices (using Bland-Altman statistics). Results: The bias for the agreement between MAIA3 and MAIA2 measurements was below the established International Organization for Standardization standard of <1 decibel (dB). Healthy participants showed a bias of 0.39 dB for both MS and PWS, 95% confidence interval (CI): 0.11-0.67 dB for MS, 0.30-0.48 dB for PWS. The bias in retinal patients was 0.76 dB (CI: 0.40-1.12 for MS, 0.59-0.93 dB for PWS). The overall bias was 0.57 dB (CI: 0.35-0.80 dB for MS and 0.48-0.67 dB for PWS). Overall TRT repeatability was similar between MAIA3 and MAIA2 devices for MS (Bland-Altman 95% limits of repeatability: -1.16 to 1.53 dB for MAIA3 and -1.49 to 2.06 dB for MAIA2). The examination duration with the MAIA3 device was shorter by 43 seconds compared with the MAIA2 device (median duration: 482.5 seconds [IQR: 451.8-537.5 seconds] for MAIA3 vs. 525.5 seconds [IQR: 500.8-562.3 seconds] for MAIA2). Conclusions: The MAIA3 microperimetry enables valid and reliable measurements of macular light sensitivity compared with the established device (MAIA2). Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.